Authors: MAEDA YY TAKAHAMA S YONEKAWA H

Citation: Yy. Maeda et al., 4 DOMINANT LOCI FOR THE VASCULAR-RESPONSES BY THE ANTITUMOR POLYSACCHARIDE, LENTINAN, Immunogenetics, 47(2), 1998, pp. 159-165

Authors: MAEDA YY TAKAHAMA S KOHARA Y YONEKAWA H

Citation: Yy. Maeda et al., POLYGENIC CONTROL OF THE EXPRESSION OF BIOLOGICAL-ACTIVITIES OF AN ANTITUMOR POLYSACCHARIDE, LENTINAN, International journal of immunopharmacology, 19(9-10), 1997, pp. 469-472

Authors: MAEDA YY TAKAHAMA S KOHARA Y YONEKAWA H

Citation: Yy. Maeda et al., 2 GENES-CONTROLLING ACUTE-PHASE RESPONSES BY THE ANTITUMOR POLYSACCHARIDE, LENTINAN, Immunogenetics, 43(4), 1996, pp. 215-219

Authors: SUZUKI M TAKATSUKI F MAEDA YY HAMURO J CHIHARA G

Citation: M. Suzuki et al., LENTINAN - RATIONALE FOR DEVELOPMENT AND THERAPEUTIC POTENTIAL, CLINICAL IMMUNOTHERAPEUTICS, 2(2), 1994, pp. 121-133

Authors: SUZUKI M TAKATSUKI F MAEDA YY HAMURO J CHIHARA G

Citation: M. Suzuki et al., ANTITUMOR AND IMMUNOLOGICAL ACTIVITY OF LENTINAN IN COMPARISON WITH LPS, International journal of immunopharmacology, 16(5-6), 1994, pp. 463-468